| Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2 JW Antoon, MD White, EM Slaughter, JL Driver, HS Khalili, S Elliott, ... Cancer biology & therapy 11 (7), 678-689, 2011 | 173 | 2011 |
| Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640 JW Antoon, MD White, WD Meacham, EM Slaughter, SE Muir, S Elliott, ... Endocrinology 151 (11), 5124-5135, 2010 | 127 | 2010 |
| Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence LV Rhodes, SE Muir, S Elliott, LM Guillot, JW Antoon, P Penfornis, ... Breast cancer research and treatment 121, 293-300, 2010 | 125 | 2010 |
| Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk LV Rhodes, JW Antoon, SE Muir, S Elliott, BS Beckman, ME Burow Molecular cancer 9, 1-15, 2010 | 123 | 2010 |
| Pediatric fever of unknown origin JW Antoon, NM Potisek, JA Lohr Pediatrics in review 36 (9), 380-391, 2015 | 73 | 2015 |
| Factors associated with COVID‐19 disease severity in US children and adolescents JW Antoon, CG Grijalva, C Thurm, T Richardson, AB Spaulding, RJT II, ... Journal of hospital medicine 16 (10), 603-610, 2021 | 72 | 2021 |
| Incidence, outcomes, and resource use in children with Stevens‐Johnson syndrome and toxic epidermal necrolysis JW Antoon, JL Goldman, B Lee, A Schwartz Pediatric dermatology 35 (2), 182-187, 2018 | 60 | 2018 |
| Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells EC Martin, S Elliott, LV Rhodes, JW Antoon, C Fewell, Y Zhu, JL Driver, ... Molecular carcinogenesis 53 (1), 38-48, 2014 | 59 | 2014 |
| Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer JW Antoon, WD Meacham, MR Bratton, EM Slaughter, LV Rhodes, ... Journal of molecular endocrinology 46 (3), 205-216, 2011 | 59 | 2011 |
| COVID-19 and acute neurologic complications in children JW Antoon, M Hall, LM Howard, A Herndon, KL Freundlich, CG Grijalva, ... Pediatrics 150 (5), e2022058167, 2022 | 52 | 2022 |
| MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis JW Antoon, EC Martin, R Lai, VA Salvo, Y Tang, AM Nitzchke, S Elliott, ... PloS one 8 (8), e69291, 2013 | 52 | 2013 |
| Children with reported penicillin allergy: public health impact and safety of delabeling D Vyles, JW Antoon, A Norton, CA Stone Jr, J Trubiano, A Radowicz, ... Annals of Allergy, Asthma & Immunology 124 (6), 558-565, 2020 | 50 | 2020 |
| Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells JW Antoon, J Liu, MM Gestaut, ME Burow, BS Beckman, M Foroozesh Journal of medicinal chemistry 52 (18), 5748-5752, 2009 | 49 | 2009 |
| Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives CH Walker, BA Drew, JW Antoon, AV Kalueff, BS Beckman Cancer investigation 30 (2), 135-148, 2012 | 48 | 2012 |
| The COVID‐19 pandemic and changes in healthcare utilization for pediatric respiratory and nonrespiratory illnesses in the United States JW Antoon, DJ Williams, C Thurm, M Bendel‐Stenzel, AB Spaulding, ... Journal of hospital medicine 16 (5), 294-297, 2021 | 46 | 2021 |
| Synthesis of 2, 2′‐bipyridyl‐type compounds via the suzuki‐miyaura cross‐coupling reaction NA Jones, JW Antoon, AL Bowie Jr, JB Borak, EP Stevens Journal of Heterocyclic Chemistry 44 (2), 363-367, 2007 | 44 | 2007 |
| Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition JW Antoon, AM Nitzchke, EC Martin, LV Rhodes, S Nam, S Wadsworth, ... International journal of oncology 42 (4), 1139-1150, 2013 | 42 | 2013 |
| Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640 MD White, L Chan, JW Antoon, BS Beckman Anticancer research 33 (9), 3573-3579, 2013 | 40 | 2013 |
| Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation JW Antoon, MR Bratton, LM Guillot, S Wadsworth, VA Salvo, ME Burow Cancer biology & therapy 13 (11), 1026-1033, 2012 | 39* | 2012 |
| Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance JW Antoon, MD White, ME Burow, BS Beckman Oncology reports 27 (6), 1779-1786, 2012 | 39 | 2012 |
